Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/all.14449 http://scihub22266oqcxt.onion/10.1111/all.14449 32535955!7323196!32535955     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Allergy 2020 ; 75 (10): 2503-2541 Nephropedia Template TP {{tp|p=32535955|t=2020. A compendium answering 150 questions on COVID-19 and SARS-CoV-2 |pdf=|usr=}}{{32535955}} gab.com Text A compendium answering 150 questions on COVID-19 and SARS-CoV-2 JO: Allergy http://www.kidney.de/pget.php?&tw=1&pmid=32535955 #FOAvip In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in ~9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease. Twit Text FOAVip A compendium answering 150 questions on COVID-19 and SARS-CoV-2 ????Allergy http://www.kidney.de/pget.php?&tw=1&pmid=32535955 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32535955 #FOAvip English Wikipedia <ref>{{Cite pmid|32535955}}</ref> A compendium answering 150 questions on COVID-19 and SARS-CoV-2 #MMPMID32535955 Riggioni C; Comberiati P; Giovannini M; Agache I; Akdis M; Alves-Correia M; Anto JM; Arcolaci A; Azkur AK; Azkur D; Beken B; Boccabella C; Bousquet J; Breiteneder H; Carvalho D; De Las Vecillas L; Diamant Z; Eguiluz-Gracia I; Eiwegger T; Eyerich S; Fokkens W; Gao YD; Hannachi F; Johnston SL; Jutel M; Karavelia A; Klimek L; Moya B; Nadeau KC; O'Hehir R; O'Mahony L; Pfaar O; Sanak M; Schwarze J; Sokolowska M; Torres MJ; van de Veen W; van Zelm MC; Wang Y; Zhang L; Jimenez-Saiz R; Akdis CA Allergy 2020[Oct]; 75 (10): 2503-2541 PMID32535955show ga In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in ~9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease. |Betacoronavirus/*immunology[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/*diagnosis/*therapy[MESH] |Humans[MESH] |Hypersensitivity/*complications/immunology/*therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/*diagnosis/*therapy[MESH]A compendium answering 150 questions on COVID-19 and SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing